Our study demonstrated that CC, with or without the use of the ABC tool, is an effective method for glycemic control in individuals diagnosed with T1DM, yielding an average reduction of −0.94% in HbA1c compared with the traditional fixed‐dose insulin application method. The gene discussed is INS; the disease is type 1 diabetes mellitus.